Statehouse Report 24.20: Earmarks, Abortion, Film - Statehouse
12 Articles
12 Articles
Feds agree to review mifepristone safety based on anti-abortion research
Demonstrators gathered in front of the U.S. Supreme Court as justices heard arguments in March 2024 about medication abortion, the most common method in 2023, according to the Guttmacher Institute. (Anna Rose Layden/Getty Images).The Trump administration has agreed to review the safety and efficacy of abortion pills, based on white papers funded by far-right organizations, which reproductive health experts say are unscientific and contradict dec…

HHS agrees to review mifepristone safety based on anti-abortion white papers
Demonstrators gathered in front of the U.S. Supreme Court as justices heard arguments in March 2024 about medication abortion, the most common method in 2023, according to the Guttmacher Institute. (Photo by Anna Rose Layden/Getty Images)The Trump administration has agreed to review the safety and efficacy of abortion pills, based on white papers funded by far-right organizations, which reproductive health experts say are unscientific and contra…
FDA Review of Abortion Pill Signals First Step Toward Nationwide Ban
In a stunning move that could mark the first step toward a nationwide ban on abortion pills, Health and Human Services Secretary Robert F. Kennedy Jr. has ordered the FDA to reevaluate its decades-old approval of mifepristone—a medication used safely by over 7.5 million Americans over the last quarter-century for abortion and treatment of miscarriages. The directive, based on a single junk-science report from an antiabortion group, signals a dan…
Coverage Details
Bias Distribution
- 67% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage